260 related articles for article (PubMed ID: 9682345)
1. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H
Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345
[TBL] [Abstract][Full Text] [Related]
2. A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice.
Li Z; Wang J; Yuan D; Wang S; Sun J; Yi B; Hou Q; Mao Y; Liu W
Virus Genes; 2015 Jun; 50(3):434-41. PubMed ID: 25764477
[TBL] [Abstract][Full Text] [Related]
3. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
[TBL] [Abstract][Full Text] [Related]
5. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
6. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
7. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
9. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
[TBL] [Abstract][Full Text] [Related]
10. Characterization of canine herpesvirus glycoprotein C expressed by a recombinant baculovirus in insect cells.
Xuan X; Maeda K; Mikami T; Otsuka H
Virus Res; 1996 Dec; 46(1-2):57-64. PubMed ID: 9029777
[TBL] [Abstract][Full Text] [Related]
11. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
[TBL] [Abstract][Full Text] [Related]
12. Analysis of canine herpesvirus gB, gC and gD expressed by a recombinant vaccinia virus.
Xuan X; Kojima A; Murata T; Mikami T; Otsuka H
Arch Virol; 1997; 142(5):1003-10. PubMed ID: 9191864
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
Faber M; Dietzschold B; Li J
Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
[TBL] [Abstract][Full Text] [Related]
15. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
16. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
[TBL] [Abstract][Full Text] [Related]
17. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.
Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA
Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661
[TBL] [Abstract][Full Text] [Related]
18. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
[TBL] [Abstract][Full Text] [Related]
19. Rabies vaccine development by expression of recombinant viral glycoprotein.
Astray RM; Jorge SA; Pereira CA
Arch Virol; 2017 Feb; 162(2):323-332. PubMed ID: 27796547
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]